Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
J Kotsopoulos, J Gronwald, T Huzarski, A Aeilts… - Breast Cancer Research …, 2023 - Springer
Purpose Chemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Hereditary Breast Cancer Clinical … - Breast Cancer …, 2023 - ohiostate.elsevierpure.com
Purpose: Chemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Hereditary Breast Cancer Clinical … - Breast Cancer …, 2023 - scholars.northwestern.edu
Purpose: Chemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
J Kotsopoulos, J Gronwald, T Huzarski… - … Cancer Research and …, 2023 - europepmc.org
Purpose Chemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
J Kotsopoulos, J Gronwald, T Huzarski… - BREAST CANCER …, 2023 - boa.unimib.it
Purpose: Chemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
J Kotsopoulos, J Gronwald, T Huzarski… - … Cancer Research and …, 2023 - escholarship.org
PurposeChemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
J Kotsopoulos, J Gronwald… - Breast cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Chemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Hereditary Breast Cancer Clinical … - Breast Cancer …, 2023 - mayoclinic.elsevierpure.com
Purpose: Chemoprevention with a selective estrogen receptor modulator (tamoxifen or
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …
raloxifene) is a non-surgical option offered to high-risk women to reduce the risk of breast …